{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:38:53Z","timestamp":1772077133824,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.vaccine.2013.06.049","type":"journal-article","created":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T20:00:17Z","timestamp":1378065617000},"page":"5486-5494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain"],"prefix":"10.1016","volume":"31","author":[{"given":"Javier","family":"Diez-Domingo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Gurtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Bernaola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Gimenez-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Martinon-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Pineda-Solas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Infante-Marquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Z.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio A.","family":"Emini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.06.049_bib0005","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/INF.0b013e31817bd2dc","article-title":"Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine","volume":"27","author":"Casado-Flores","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0010","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease \u2013 United States, 1998\u20132003","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.06.049_bib0020","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Active Bacterial Core Surveillance\/Emerging Infections Program Network Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0040","unstructured":"GSP Summary Report (Stage 1; Version 1) for SAGE meeting November 6\u20138, 2007; October 18, 2007 version (public document)."},{"key":"10.1016\/j.vaccine.2013.06.049_bib0045","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.inf.0000207409.92198.6f","volume":"25","author":"Black","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0050","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1016\/S0264-410X(03)00389-X","article-title":"The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine","volume":"21","author":"Schmitt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0055","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1016\/j.vaccine.2010.04.008","article-title":"Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany","volume":"28","author":"Kieninger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0060","series-title":"Poster presented at the Infectious Diseases Society of America (IDSA) 47th Annual Meeting, October 29\u2013November 1","article-title":"Immunogenicity of Infanrix\u00ae hexa\/Infanrix\u00ae-IPV+Hib when coadministered with 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers","author":"Gimenez-Sanchez","year":"2009"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0065","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/CDLI.10.4.514-519.2003","article-title":"Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0075","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0080","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.0006-341X.1999.01202.x","article-title":"Test based exact confidence intervals for the difference of two binomial proportions","volume":"55","author":"Chan","year":"1999","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0085","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"J\u00f3dar","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0090","series-title":"World Health Organization Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series, No. 927","year":"2005"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0095","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1086\/315761","article-title":"Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries","volume":"182","author":"Henriques","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0100","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1017\/S0950268806007199","article-title":"Burden of paediatric invasive pneumococcal disease in Europe, 2005","volume":"135","author":"McIntosh","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10096-004-1197-2","article-title":"Pneumococcal bacteremia in children: an 8-year review in two hospitals in Barcelona","volume":"23","author":"P\u00e9rez","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0110","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1469-0691.2008.02031.x","article-title":"Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine","volume":"14","author":"Aguiar","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0115","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.diagmicrobio.2009.10.012","article-title":"Epidemiology of pediatric community-acquired bloodstream infections in a children hospital in Paris, France, 2001 to 2008","volume":"66","author":"Doit","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.diagmicrobio.2009.05.009","article-title":"ORP Ile de France Ouest Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology","volume":"65","author":"Dortet","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0125","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1469-0691.2009.02904.x","article-title":"Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain","volume":"15","author":"Guevara","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2009.05.012","article-title":"Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona","volume":"59","author":"Mu\u00f1oz-Almagro","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0135","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1469-0691.2009.02938.x","article-title":"Changes in serotypes causing invasive pneumococcal disease (2005\u20132007 vs 1997\u20131999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine","volume":"15","author":"Salleras","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0140","series-title":"Poster presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)\/Infectious Diseases Society of America (IDSA) 46th Annual Meeting, October 25\u201328","article-title":"Immunogenicity of DTaP-IPV-Hib and MenC vaccines in the UK when administered with a 13-valent pneumococcal conjugate vaccine [abstract]","author":"Snape","year":"2008"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/INF.0b013e31824b972b","article-title":"13-Valent pneumococcal conjugate vaccine given with meningococcal C tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety","volume":"31","author":"Martin\u00f3n-Torres","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0150","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"J\u00f3dar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0155","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0264-410X(00)00241-3","article-title":"A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants","volume":"19","author":"English","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00006454-200102000-00007","article-title":"Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants","volume":"20","author":"Rennels","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0165","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0170","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1001\/jama.293.14.1751","article-title":"Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial","volume":"293","author":"Buttery","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0175","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199710023371404","article-title":"Bacterial meningitis in the United States in 1995. Active Surveillance Team","volume":"337","author":"Schuchat","year":"1997","journal-title":"N Engl J Med"},{"issue":"4 (Suppl.)","key":"10.1016\/j.vaccine.2013.06.049_bib0180","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0185","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.vaccine.2009.02.022","article-title":"Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants","volume":"27","author":"Lagos","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0190","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1016\/j.vaccine.2008.05.072","article-title":"Safety and immunogenicity of CRM197-conjugated pneumococcal-meningococcal C combination vaccine (9vPnC-MnCC) whether given in two or three primary doses","volume":"26","author":"Sigurdardottir","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0195","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CVI.00420-08","article-title":"Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom","volume":"16","author":"Southern","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.049_bib0200","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0205","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/509619","article-title":"Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom","volume":"194","author":"Auckland","year":"2006","journal-title":"J Infect Dis"},{"issue":"4 (Suppl.)","key":"10.1016\/j.vaccine.2013.06.049_bib0210","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/INF.0b013e318199f609","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines","volume":"28","author":"Wysocki","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0215","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1016\/j.vaccine.2010.09.047","article-title":"Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines","volume":"28","author":"Wysocki","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0220","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0225","series-title":"Poster presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)\/Infectious Diseases Society of America (IDSA) 46th Annual Meeting, October 25\u201328","article-title":"A phase 3 trial evaluating the safety, tolerability and immunogenicity of manufacturing scale 13-valent pneumococcal conjugate vaccine [abstract]","author":"Gadzinowski","year":"2008"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0230","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.inf.0000151022.92222.be","article-title":"Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age","volume":"24","author":"K\u00e4yhty","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"4 (Suppl.)","key":"10.1016\/j.vaccine.2013.06.049_bib0235","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.06.049_bib0240","series-title":"Cumulative weekly number of reports of invasive pneumococcal disease due to any of the seven serotypes in PrevenarTM: children aged <2 years in England and Wales by epidemiological year: July\u2013June (2005- to date)","author":"Public Health England","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:38:42Z","timestamp":1596415122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13008414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":48,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0264410X13008414"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}